BHCAG Summit Minneapolis, MN February 23, 2012 Shannon Brownlee, MS Instructor, The Dartmouth Institute Acting Director, New America Foundation Health.

Slides:

Advertisements

Similar presentations

Ranexa™ for Chronic Angina An Unmet Need

Advertisements

Implementation of Evidence Based Treatment: Factors that Promote and Impede Guideline Implementation OBSERVATIONS FROM GENERAL MEDICAL CARE R. Michael.

CABG VS Multi Vessel PCI Hasanat Sharif MD FRCS Chief of Cardiorthoracic Surgery Aga Khan University Hospital.

Arizona Adult Tobacco Survey Response to Health Professional Query Behavior Richard S. Porter, MS Bob Leischow, MPH Arizona Department of Health Services.

The Role of Shared Decision Making in Reducing Unwarranted Variation in Health Care A Talk by Jack Wennberg A Talk by Jack Wennberg Implementing shared.

Physician Progress Record JACC Appropriateness Figures 2, 3 and 4

Cardiology Morning Report: Revascularization in Stable Ischemic Heart Disease Bobby Mathew, MD LSU Internal Medicine, HO-II.

Middle Atlantic Actuarial Club September 17, 2009 Baltimore, MD Shannon Brownlee, MS Senior Research Fellow, New America Foundation Overtreated: Why Too.

To stent or not to stent Clinical Utility of Fractional Flow Reserve.

Cancer Clinical Trials: The Way We Make Progress Against Cancer.

The Other Side of Health Care Costs: Is improved technology making a difference? Health care costs have increased dramatically over the past decade - largely.

How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.

Better Shared Decision Making in Practice

Promoting Shared Decision Making Jack Fowler Informed Medical Decisions Foundation.

1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.

Shared Decision Making An Overview of Knowledge, Policy and Quality Measurement Michael J. Barry, MD President March 2, 2011 Medical Directors Meeting.

The Heart of the Matter A Journey through the system of care.

New guidelines for CABG

Health Policy Seminar on Sunday, April 19 th, 2009 Washington, D.C. Shannon Brownlee Visiting Scholar, NIH Clinical Center Dept. of Bioethics Schwartz.

The Impact of Regional ST-Elevation Myocardial Infarction Systems of Care on the Use of Protocols and Quality Improvement Initiatives in Community Hospitals.

The Impact of Regional ST-Elevation Myocardial Infarction Systems of Care on the Use of Protocols and Quality Improvement Initiatives in Community Hospitals.

Health Disparities and Multicultural Practice Clarence H. Braddock III, MD, MPH, FACP Associate Professor of Medicine Associate Dean, Medical Education.

CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.

Shared Decision Making MAGIC — Making Good decisions In Collaboration — Shared decision making the norm — Multi-centre, large scale implementation programme.

Disclosures The presenter has no financial involvement with the product or competing products being discussed. The presenter received travel and lodging.

What the College is doing for you & High Value Care Robert H. Lohr, MD, FACP Board of Regents American College of Physicians.

Cardiac Rehabilitation 2011 Update for Primary Care Providers Douglass A Morrison, MD, PhD Cardiac Rehabilitation, Medical Director Yakima Regional and.

Quality of care, part 4: MI Kim A Eagle MD Albion Walter Hewlett Professor of Internal Medicine Chief, Clinical Cardiology Co-Director, Heart Care Program.

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.

VA National Center for Health Promotion and Disease Prevention Using USPSTF Recommendations in VHA Clinical Practice Linda Kinsinger, MD, MPH Chief Consultant.

What is shared decision making? Richard Thomson Professor of Epidemiology and Public Health Associate Dean for Patient and Public Engagement Decision Making.

Plenary III: There is No Health Without Mental Health.

Heterogeneity and Comparative Effectiveness: Implications for Studies, Reviews, and Policy David Atkins, MD, MPH Health Services Research and Development.

Bangalore S, et al. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012;308(13): ?

Promoting Patient Involvement in Medication Decisions David H. Hickam, MD, MPH Professor, Dept. of Medicine Oregon Health & Science University Portland,

The Challenge of Practice Variations And the Future of Primary Care 2009 Blanchard Memorial Lecture John E. Wennberg May 1, 2009.

University of Texas System, Clinical Safety and Effectiveness Conference Building the Bridge: Maintaining Quality in the Face of Change September 20-21,

The ABCS Metrics the evidence, the conversation, and the decision LJ Fagnan, MD, and the H2N team April 27, 2016 This project is supported by grant number.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: AACVPR/ACC/AHA 2007 Performance Measures on Cardiac.

Patient Beliefs Regarding Benefits of Percutaneous Coronary Intervention in Chronic Stable Angina My Summer Research Project of 2014 Carla Lauture, of.

Date of download: 6/24/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Cardiovascular Surgery J Am Coll Cardiol.

Society of Teachers of Family Medicine Conference on Practice Improvement November 23, 2013 Michael J Barry, President SHARED DECISION MAKING THE PINNACLE.

Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.

How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.

PCI Appropriateness: Evidence and Tools Direct US

Prof. Dr. med. Sigmund Silber Cardiology Practice and Hospital

DISCLOSURE Executive Director Accreditation for Cardiovascular Excellence.

Value of Pharmaceuticals in Managed Care Pharmacy

The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions

Adjusted odds ratio 95% CI Diagnostic angiography PCI CABG

Value of Pharmaceuticals in Managed Care Pharmacy

Glenn N. Levine et al. JACC 2016;68:

Technological innovation in cardiothoracic surgery: A pragmatist's approach Pedro J. del Nido, MD The Journal of Thoracic and Cardiovascular Surgery

STEMI-INITIAL PRESENTATION TIMING 2013 ACC/AHA GUIDELINES

Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery

Peter K. Smith, MD The Annals of Thoracic Surgery

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Risk Stratification and Interventional Cardiology: Robert L

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.

Disparities in Serious Illness Care for African Americans

P. Michael Grossman et al. JCIN 2009;2:

Chest Pain Choice Trial design: Patients presenting to the ED with low risk chest pain were randomized to either use of a tailored decision aid or routine.

Atlantic Cardiovascular Patient Outcomes Research Team

Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.

Glenn N. Levine et al. JACC 2011;58:e44-e122

Lee A. Fleisher et al. JACC 2014;64:e77-e137

Evidence Based Care & Resource Stewardship

Davide Capodanno et al. JCIN 2009;2:

P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.

Presentation transcript:

BHCAG Summit Minneapolis, MN February 23, 2012 Shannon Brownlee, MS Instructor, The Dartmouth Institute Acting Director, New America Foundation Health Policy

Clinicians, patients and preference- sensitive (elective) care What do patients know about tradeoffs? What do they need to know? What do clinicians know about patient preferences? How does knowledge change behavior?

Jack Fowler Michael Barry Al Mulley Jack Wennberg

Involves tradeoffs -- more than one treatment exists; not getting treated is often an option; and the outcomes are different Decisions should be based on the patient’s preferences... But provider opinion/preference often determines which treatment is delivered

PCI per 1,000 Enrollees (2003 – 2007)

“Yes, medical therapy is as effective as PCI, but when I see a lesion, the bottom line is that the oculostenotic reflex always wins out.” “[The patient] is not going to get out of the cath lab without a stent.” Grace A. Lin, et al ARCH INTERN MED/VOL 167 (NO. 15), AUG 13/27, 2007

WHAT DO PATIENTS KNOW (1990s)? 75% believed PCI would help prevent an MI 71% believed PCI would help them live longer Less than half could name even one possible complication of PCI 85% were “consented” just before the procedure (by a fellow or an NP) From a survey of consecutive patients scheduled for an elective coronary revascularization procedure at Yale New Haven Hospital in (Holmboe ES. JGIM 2000; 15:632)

What patients know (2010)... 88% believed PCI would help prevent an MI 76% believed PCI would help them live longer (Baystate Medical Center in Rothberg MB. Annals Intern Med 2010; 153:307)

Only 31% had activity limiting chest pain C ardiologists’ perception of the patient’s angina was often greater than the patient’s MB Rothberg Ann Intern Med Sep 7;153(5):307-1

What drives utilization? Well Bob, it looks like a paper cut, but just to be sure, I like to do lots of catheterizations.

H. Vernon Anderson et al Circulation 2005;112; Relationship Between Procedure Indications and Outcomes of Percutaneous Coronary Interventions by American College of Cardiology/American Heart Association Task Force Guidelines

CABG in Minnesota

What do clinicians know about what their patients prefer? U. Mich Decision Survey

What do Clinicians Know? Sepucha K, et al. Patient Education and Counseling 2008 and Lee et al. 30th Annual Society for Medical Decision Making Conference, Philadelphia, 2008.

DECISION Survey: How can you know if you don’t ask? Surgery: About 1/2 the time for the orthopedic surgeries; 1/3 for cataracts Screening: Less than 1/5 of the time for decisions about cancer screening Medications: About 1/3 of the time SOURCE: U. of Mich. DECISION Survey

What do patients know? Clinical experts identified 4-5 facts, e.g. common side effects Respondents were asked the knowledge questions related to their decision. For 8 out of the 10 decisions, less than half of respondents could get more than 1 of the knowledge questions right. U. Mich Decision Survey

Clinicians, patients and preference- sensitive care What do patients know about tradeoffs? Not much What do they need to know? A lot more What do clinicians know about patient preferences? Not much How does knowledge change behavior?

* P <.01 Source: N. Cochran, MD, WRJ V.A. Behavior Behavior Changes with Knowledge GREATER KNOWLEDGE LEADS TO DIFFERENT CHOICES